Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-10 4:32 pm Purchase | 2024-12-04 | 13G | Pacific Biosciences of California, Inc. PACB | Integrated Core Strategies (US) LLC | 16,443,656 6.000% | 4,046,919 (+32.65%) | Filing History |
| 2024-11-26 8:27 pm Purchase | 2024-11-21 | 13G | Pacific Biosciences of California, Inc. PACB | SOFTBANK GROUP CORP. | 20,451,570 7.500% | 20,451,570 (New Position) | Filing History |
| 2024-11-14 5:52 pm Purchase | 2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB | EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) | 20,307,880 7.500% | 20,307,880 (New Position) | Filing History |
| 2024-11-14 5:48 pm Purchase | 2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB | MADRONE CAPITAL PARTNERS LLC | 26,891,915 9.900% | 5,800,000 (+27.50%) | Filing History |
| 2024-11-12 4:43 pm Unchanged | 2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB | The Vanguard Group | 17,642,751 6.470% | 0 (Unchanged) | Filing History |
| 2024-11-08 4:16 pm Purchase | 2024-11-04 | 13G | Pacific Biosciences of California, Inc. PACB | Integrated Core Strategies (US) LLC | 12,396,737 4.500% | 12,396,737 (New Position) | Filing History |
| 2024-11-04 10:47 am Sale | 2024-09-30 | 13G | Pacific Biosciences of California, Inc. PACB | The Vanguard Group | 17,642,751 6.470% | -9,146,748 (-34.14%) | Filing History |
| 2024-02-13 4:15 pm Purchase | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | MADRONE CAPITAL PARTNERS LLC | 21,091,915 7.900% | 1,175,982 (+5.90%) | Filing History |
| 2024-02-12 5:12 pm Sale | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Nikko Asset Management Americas Inc. | 13,200,375 4.930% | -965,818 (-6.82%) | Filing History |
| 2024-02-09 06:42 am Sale | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Jackson Square Partners LLC | 9,704,766 3.630% | -5,300,411 (-35.32%) | Filing History |
| 2024-02-05 06:08 am Sale | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Sumitomo Mitsui Trust Group Inc. | 13,200,375 4.930% | -965,818 (-6.82%) | Filing History |
| 2024-01-29 4:01 pm Purchase | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | ARK Investment Management LLC | 34,504,273 12.900% | 8,812,592 (+34.30%) | Filing History |
| 2024-01-24 5:23 pm Purchase | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | BlackRock Inc. BLK | 24,642,666 9.200% | 6,108,207 (+32.96%) | Filing History |
| 2024-01-10 10:16 am Purchase | 2023-12-29 | 13G | Pacific Biosciences of California, Inc. PACB | The Vanguard Group | 26,789,499 10.020% | 6,510,464 (+32.10%) | Filing History |
| 2023-02-13 4:03 pm Purchase | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | MADRONE CAPITAL PARTNERS LLC | 19,915,933 8.800% | 3,000,000 (+17.73%) | Filing History |
| 2023-02-13 3:54 pm Sale | 2023-02-14 | 13G | Pacific Biosciences of California, Inc. PACB | Capital International Investors | 6,099,681 2.700% | -6,006,637 (-49.62%) | Filing History |
| 2023-02-10 1:48 pm Sale | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | ARK Investment Management LLC | 25,691,681 11.360% | -691,422 (-2.62%) | Filing History |
| 2023-02-10 10:29 am Purchase | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Nikko Asset Management Americas Inc. | 14,166,193 6.260% | 2,251,168 (+18.89%) | Filing History |
| 2023-02-09 7:12 pm Sale | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Jackson Square Partners LLC | 15,005,177 6.640% | -7,418,738 (-33.08%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Pacific Biosciences of California, Inc. PACB | The Vanguard Group | 20,279,035 8.970% | 424,159 (+2.14%) | Filing History |